Members of the Khondrion team will be attending Mitochondrial Medicine 2019 on 11-13 December 2019. The event will bring together leaders in the field of translational mitochondrial medicine, with a programme designed to engage and inspire the next generation of mitochondrial researchers. Read more about the event.
Find more articles
- Patient Perspective: A conversation with Sean Murray – CEO, The Mito Foundation
- Interview with Tom Pulles, Chief Medical Officer at Khondrion
- Khondrion to participate in mitoNice international congress dedicated to mitochondrial medicine
- Patient Perspective: A conversation with Kasey Woleben – Co-founder, and Sophia Zilber – Board Member, Patient Registry Director, Cure Mito Foundation
- Khondrion appoints Tom Pulles, MD, as Chief Medical Officer
- Patient Perspective: A conversation with Philip Yeske, PhD – Science & Alliance Officer, UMDF
- Patient Perspective: A conversation with Alison Maguire – Head of Research & Finance, The Lily Foundation
- Patient Perspective: A conversation with Kira Mann – Newly appointed IMP Chair
- Khondrion completes enrollment in KHENERGYZE Phase IIb trial evaluating sonlicromanol in adult patients with MELAS spectrum disorders
- 2021 – A Year in Review
- Movement disorders in children with primary mitochondrial disease
- A coffee with the Scientific Advisory Board: Prof. Dr. Anu Suomalainen Wartiovaara
- A coffee with the Scientific Advisory Board: Prof. Dr. Shamima Rahman
- Khondrion announces first patients dosed in KHENEREXT Phase IIb extension study examining long-term safety and efficacy of oral sonlicromanol in mitochondrial disease patients
- Khondrion to participate in Mitocon’s 11th Italian Meeting on Mitochondrial Diseases
- Khondrion moves headquarters to Novio Tech Campus to support growth
- Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol’s active metabolite
- Patient Perspective: A conversation with Elja van der Veer – Former IMP Chair
- Khondrion to attend UMDF Mitochondrial Medicine Symposium 2021
- A coffee with the Scientific Advisory Board: Prof. Dr. Michelangelo Mancuso
- Patient Perspective: A conversation with Sam’s mother
- A coffee with the Scientific Advisory Board: Prof. Dr. Marni Falk
- Khondrion announces first patients dosed in 6-month paediatric Phase II study of sonlicromanol for mitochondrial diseases
- Khondrion to present at MITO2i Inaugural Research Symposium on mitochondrial medicine and research
- Patient Perspective: A conversation with Paulien